Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

polarean (POLX) Share News

123456

IN BRIEF: Polarean Imaging wins order for new polariser

3rd May 2024 15:40

Polarean Imaging PLC - London-based medical imaging technology developer - Receives an order for a new polariser to replace the research polariser at Cincinnati Children's Hospital Medical Center. "Cincinnati Children's previously purchased the first clinical polariser and continues to demonstrate a commitment to the future of Xenon MRI for challenging lung diseases. Cincinnati Children's performs hospital clinical imaging on both children and adults (from their neighbouring partner institution, UC Medical Centre)," Polarean says. Read More

TRADING UPDATES: Nexteq confident of meeting full-year expectations

16th Apr 2024 20:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Polarean Imaging shares sink after announcing a costly strategic plan

29th Feb 2024 14:28

(Alliance News) - Polarean Imaging PLC shares dropped on Thursday, after the company said it would need to find an additional USD10 million to finance its medium-term ambitions. Read More

IN BRIEF: Polarean Imaging strategic parter raises stake to above 10%

15th Jan 2024 11:21

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price. Read More

IN BRIEF: Polarean shares jump on Xenoview polariser order

7th Dec 2023 12:14

Polarean Imaging PLC - London-based medical imaging technology developer - Receives its first de novo order for a new Xenoview polariser from an unnamed "top-tier" academic medical centre located in the northeast of the US. Polarean says it continues to have positive meetings and is in active negotiations with additional academic medical centres. Xenoview is a hyperpolarised contrast agent for use with magnetic imaging for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. It was approved for use in the US last year. Read More

AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean

7th Dec 2023 11:11

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

Polarean Imaging partners with Vida Diagnostics on MRI solutions

8th Sep 2023 10:27

(Alliance News) - Polarean Imaging PLC on Friday said that it has partnered with Vida Diagnostics Inc to work on advanced magnetic resonance imaging solutions for the lungs. Read More

TRADING UPDATES: Polarean withdraws commercial targets on revenue drop

7th Sep 2023 14:26

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

7th Sep 2023 11:20

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

IN BRIEF: Polarean Imaging announces code price range for Xenoview

5th Sep 2023 19:42

Polarean Imaging PLC - London-based medical imaging technology developer - Announces that following statement on August 29, the reimbursement code for the Polarean Xenoview technology has been assigned to a new technology ambulatory payment classification code which corresponds to a payment range of between USD1,201 to USD1,300 as part of the 2023 medicare hospital outpatient prospective payment system final rule. Notes the codes enables healthcare providers a path to bill for "magnetic resonance imaging with inhaled hyperpolarised xenon-129 contrast agent, chest, including preparation and administration of agent." Read More

UK earnings, trading statements calendar - next 7 days

31st Aug 2023 15:52

Read More

IN BRIEF: Polarean Imaging product cleared for US Medicare payments

29th Aug 2023 11:36

Polarean Imaging PLC - London-based medical imaging technology developer - Says the US Centers for Medicare & Medicaid Services has established a new reimbursement code for Polarean's Xenoview or 'xenon XE 129' magnetic resonance imaging technology. Code "enables healthcare providers a path to bill for 'magnetic resonance imaging with [the] inhaled hyperpolarised xenon-129 contrast agent...including preparation and administration of agent'." Polarean expects to be informed of the new code's payment level "in the coming weeks". Read More

IN BRIEF: Polarean hails US FDA approval on Philips MRI configuration

3rd Aug 2023 11:31

Polarean Imaging PLC - London-based medical imaging technology company - Receives 510(k) clearance from the US Food & Drug Administration for its specialised magnetic resonance imaging chest coil. The coil may now include Philips 3.0T MRI scanners for the visualisation of the Xenon-129 nuclei. Read More

TRADING UPDATES: Touchstone wells shut in, Trident quarter receipts up

31st Jul 2023 16:17

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

28th Jun 2023 20:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

21st Jun 2023 15:43

Read More

IN BRIEF: Polarean hires new CEO as Richard Hullihen retires

21st Jun 2023 11:01

Polarean Imaging PLC - London-based medical imaging technology company - Hires Brainsway Chief Executive Officer Christopher von Jako as new CEO. Says he will be succeeding CEO Richard Hullihen, who will be retiring after seven years in the role, and will also be stepping down as director of the company immediately. Read More

Polarean shares jump after unveiling collaboration with Philips

2nd Jun 2023 19:35

(Alliance News) - Polarean Imaging PLC shares jumped on Friday after it unveiled a collaboration with Philips to advance the field of hyperpolarised Xenon MRI. Read More

Polarean shares down despite narrowed annual loss and optimism

26th May 2023 10:51

(Alliance News) - Polarean Imaging PLC shares were down on Friday despite slimming its annual loss, as the company said it now will focus on gaining commercial traction and exploring further financing for its newly US Food & Drug Administration-approved Xenoview device. Read More

TRADING UPDATES: Capital Metals to appeal Sri Lanka mining suspension

26th Apr 2023 16:52

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

123456
FTSE 100 Latest
Value9,424.75
Change0.00